Alterity Therapeutics (Alterity Therapeutics) Book Value per Share : $0.00 (As of Sep. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Alterity Therapeutics Book Value per Share?

Alterity Therapeutics's book value per share for the quarter that ended in Sep. 2023 was $0.00.

During the past 12 months, Alterity Therapeutics's average Book Value Per Share Growth Rate was -40.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 8.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -15.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -19.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Alterity Therapeutics was 56.60% per year. The lowest was -51.90% per year. And the median was -18.70% per year.

Alterity Therapeutics's current price is $2.20. Its book value per share for the quarter that ended in Sep. 2023 was $0.00. Hence, today's PB Ratio of Alterity Therapeutics is .

During the past 13 years, the highest P/B Ratio of Alterity Therapeutics was 66.84. The lowest was 0.05. And the median was 0.65.

Alterity Therapeutics Book Value per Share Historical Data

The historical data trend for Alterity Therapeutics's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterity Therapeutics Book Value per Share Chart

Alterity Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Book Value per Share

Get a 7-Day Free Trial

8.01

2.85

6.71

6.21

3.77

Alterity Therapeutics Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Sep19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Book Value per Share	Get a 7-Day Free Trial															4.71	-	3.77	-	-

Competitive Comparison of Alterity Therapeutics's Book Value per Share

For the Biotechnology subindustry, Alterity Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alterity Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alterity Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Alterity Therapeutics's PB Ratio falls into.

Alterity Therapeutics Book Value per Share Calculation

Alterity Therapeutics's Book Value Per Share for the fiscal year that ended in Jun. 2023 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(15.31	-	0.00)	/	4.07
	=	3.77

Alterity Therapeutics's Book Value Per Share for the quarter that ended in Sep. 2023 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(N/A	-	0.00)	/	4.07
	=	N/A

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Alterity Therapeutics (NAS:ATHE) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Alterity Therapeutics Book Value per Share Related Terms

Thank you for viewing the detailed overview of Alterity Therapeutics's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Alterity Therapeutics (Alterity Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alterity Therapeutics Ltd (NAS:ATHE) » Definitions » Book Value per Share

Comparable Companies

Traded in Other Exchanges

PBN:Germany ATH:Australia

Address

350 Collins Street, Level 14, Melbourne, VIC, AUS, 3000

Website

https://www.alteritytherapeutics.com

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.